Ranger-Rogez S, Vidal E, Weinbreck P, Sangare A, M'Boup S, Denis F. No direct relationship between HIV1/2 infection and HHV-6 antibody response in a large-scale European and African trial.
CLINICAL AND DIAGNOSTIC VIROLOGY 1995;
3:123-9. [PMID:
15566794 DOI:
10.1016/0928-0197(94)00034-r]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/17/1994] [Revised: 06/29/1994] [Accepted: 07/01/1994] [Indexed: 05/01/2023]
Abstract
BACKGROUND
Tropism of both human herpesvirus-6 (HHV-6) and human immunodeficiency virus (HIV) for CD4+ lymphocytes, and several studies on HIV enhancer transactivation by HHV-6 have suggested that HHV-6 could be implicated as a cofactor in the progression of HIV infection to AIDS.
OBJECTIVES
To determine if there is any relationship between HHV-6 infection and the course of HIV infection.
STUDY DESIGN
527 French and 558 African sera (210 from Senegal, 348 from Ivory Coast) were tested for HHV-6 titers by immunofluorescence assay (IFA). For each country, patients studied were divided into several groups; those with AIDS, those who were HIV-seropositive but symptomless, and HIV-seronegative patients.
RESULTS
No statistical difference could be found between HHV-6 prevalences or HHV-6 geometric mean titers obtained for each geographical area in the different HIV-1- and/or HIV-2-positive and HIV-negative groups. HIV patients with clinical manifestations of AIDS did not differ in percent seropositivity or distribution of titers from the HIV-asymptomatic patients or HIV-seronegative patients.
CONCLUSION
These findings suggest that there is no correlation between HHV-6 antibodies and HIV seropositivity or with the stage of HIV infection.
Collapse